Remove tag ibm
article thumbnail

STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages

STAT News

Over the past week, Areva Pharmaceuticals began marketing vials of fludarabine at a wholesale price of $2,736, a much steeper cost than the $272 charged for the same dosage by Fresenius Kabi and the $109 price tag from Teva Pharmaceuticals, according to data from IBM Micromedex, which gathers pricing data that is reported by manufacturers.

Medicine 111
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Radiology 109
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40